Expanding Horizons: Antibody Drug Conjugates in Non-Small Cell Lung Cancer
home / insights / expanding-horizons-antibody-drug-conjugates-in-non-small-cell-lung-cancer
Martin Dietrich, MD, PhD, and Wade Thomas Iams, MD, discuss the role of antibody-drug conjugates (ADCs) in non-small cell lung cancer (NSCLC) and review the various biomarkers for targeted therapy.